Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Tao Wang, PhD, Steven G.E. Marsh, PhD, Elizabeth Trachtenberg, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Guethlein A. Lisbeth, PhD, Martha Ladner, PhD, Peter Parham, PhD, Jeffrey S. Miller, MD, Sarah A. Cooley, MD MS

Blood (2014) 124 (21): 670.

https://doi.org/10.1182/blood.V124.21.670.670

Published: 2014

Journal Articles

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

Sarah Cooley, Lisbeth Guethlein, PhD, Elizabeth Trachtenberg, PhD, Martha Ladner, Xianghua Luo, Chap T Le, Tao Wang, PhD, John P. Klein, PhD, Steven G.E. Marsh, PhD, Stephen Spellman, Michael D Haagenson, MS, Daniel J. Weisdorf, MD, Peter Parham, Jeffrey S. Miller

Blood (2009) 114 (22): 665.

https://doi.org/10.1182/blood.V114.22.665.665

Published: 2009

Journal Articles

TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Unrelated Donor Haematopoietic Stem Cell Transplantation

Mariano Berro, MD, Louise Cooke, Neema P Mayor, Gustavo Kusminsky, MD, Steven G.E. Marsh, PhD, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, PhD, MRCP, MRCPath

Blood (2008) 112 (11): 3011.

https://doi.org/10.1182/blood.V112.11.3011.3011

Published: 2008

Journal Articles

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Sarah Cooley, MD, Jeffrey S. Miller, MD, Elizabeth Trachtenberg, PhD, Tracy Bergemann, PhD, Koy Saeteurn, John Klein, PhD, Lisbeth A. Guethlein, Steven G.E. Marsh, PhD, Daniel Geraghty, PhD, Peter Parham, PhD, Daniel Weisdorf, MD

Blood (2007) 110 (11): 43.

https://doi.org/10.1182/blood.V110.11.43.43

Published: 2007

Journal Articles

Matching Status at Amino Acid Positions 57 and 65 of the HLA-DPB1 Beta Chain Determines Outcome in Recipients of Unrelated Donor Haematopoietic Stem Cell Transplants.

Bronwen E. Shaw, DipRCPath, Steven G.E. Marsh, PhD, Neema P. Mayor, J. Alejandro Madrigal, PhD

Blood (2004) 104 (11): 827.

https://doi.org/10.1182/blood.V104.11.827.827

Published: 2004

Journal Articles

Increased Disease Relapse in HLA-DPB1 Matched Recipients of Unrelated Donor Transplants Is Not Confined to Pairs Matched for the Other Five HLA loci.

Bronwen E. Shaw, DipRCPath, Steven G.E. Marsh, PhD, Neema P. Mayor, J. Alejandro Madrigal, PhD

Blood (2004) 104 (11): 829.

https://doi.org/10.1182/blood.V104.11.829.829

Published: 2004

NARROW

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Unrelated Donor Haematopoietic Stem Cell Transplantation

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Matching Status at Amino Acid Positions 57 and 65 of the HLA-DPB1 Beta Chain Determines Outcome in Recipients of Unrelated Donor Haematopoietic Stem Cell Transplants.

Increased Disease Relapse in HLA-DPB1 Matched Recipients of Unrelated Donor Transplants Is Not Confined to Pairs Matched for the Other Five HLA loci.

Email alerts

ASH Publications

American Society of Hematology

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML.

TGFB1 Functional Polymorphisms: Impact on Outcome in Allogeneic Unrelated Donor Haematopoietic Stem Cell Transplantation

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

Matching Status at Amino Acid Positions 57 and 65 of the HLA-DPB1 Beta Chain Determines Outcome in Recipients of Unrelated Donor Haematopoietic Stem Cell Transplants.

Increased Disease Relapse in HLA-DPB1 Matched Recipients of Unrelated Donor Transplants Is Not Confined to Pairs Matched for the Other Five HLA loci.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only